FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| doxycycline | Doxycycline 50 mg/1 | CapsuleOral | Safecor Health, LLC | Sep 2, 2026 | 48433-158 |
| doxycycline | Doxycycline 100 mg/1 | CapsuleOral | Safecor Health, LLC | Sep 2, 2026 | 48433-159 |
| Phytonadione | Phytonadione 5 mg/1 | TabletOral | Safecor Health, LLC | Sep 2, 2026 | 48433-160 |
| ezetimibe | Ezetimibe 10 mg/1 | TabletOral | Safecor Health, LLC | Sep 2, 2026 | 48433-161 |
| Buspirone Hydrochloride | Buspirone hydrochloride 5 mg/1 | TabletOral | Cardinal Health 107, LLC | Sep 2, 2026 | 55154-0285 |
| Buspirone Hydrochloride | Buspirone hydrochloride 10 mg/1 | TabletOral | Cardinal Health 107, LLC | Sep 2, 2026 | 55154-0286 |
| Pregabalin | Pregabalin 150 mg/1 | CapsuleOral | REMEDYREPACK INC. | Sep 2, 2026 | 70518-4743 |
| Omega-3-acid ethyl esters | Omega-3-acid ethyl esters 1 g/1 | Capsule, Liquid filledOral | REMEDYREPACK INC. | Sep 2, 2026 | 70518-4744 |
| pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | Sep 2, 2026 | 72205-177 |
| pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | Sep 2, 2026 | 72205-178 |
| pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | Novadoz Pharmaceuticals LLC | Sep 2, 2026 | 72205-179 |
| Pomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | Sandoz Inc | Sep 1, 2026 | 0781-2354 |
| Pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | Sandoz Inc | Sep 1, 2026 | 0781-2358 |
| Pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | Sandoz Inc | Sep 1, 2026 | 0781-2366 |
| Pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | Sandoz Inc | Sep 1, 2026 | 0781-2369 |
| Midodrine Hydrochloride | Midodrine hydrochloride 2.5 mg/1 | TabletOral | Major Pharmaceuticals | Sep 1, 2026 | 0904-7640 |
| Midodrine Hydrochloride | Midodrine hydrochloride 5 mg/1 | TabletOral | Major Pharmaceuticals | Sep 1, 2026 | 0904-7641 |
| Midodrine Hydrochloride | Midodrine hydrochloride 10 mg/1 | TabletOral | Major Pharmaceuticals | Sep 1, 2026 | 0904-7642 |
| Metformin Hydrochloride | Metformin hydrochloride 500 mg/1 | Tablet, Extended releaseOral | Marlex Pharmaceuticals, Inc. | Sep 1, 2026 | 10135-823 |
| Metformin Hydrochloride | Metformin hydrochloride 750 mg/1 | Tablet, Extended releaseOral | Marlex Pharmaceuticals, Inc. | Sep 1, 2026 | 10135-824 |
| Cholestyramine | Cholestyramine 4 g/9g | Powder, For suspensionOral | AiPing Pharmaceutical, Inc. | Sep 1, 2026 | 11788-150 |
| Fludarabine Phosphate | Fludarabine phosphate 25 mg/mL | Injection, SolutionIntravenous | Hisun Pharmaceuticals USA, Inc. | Sep 1, 2026 | 42658-024 |
| Tiopronin | Tiopronin 100 mg/1 | Tablet, Sugar coatedOral | BioComp Pharma, Inc. | Sep 1, 2026 | 44523-053 |
| Danyelzanaxitamab | Naxitamab 40 mg/10mL | InjectionIntravenous | BTG International Inc. | Sep 1, 2026 | 50633-230 |
| Clonazepam | Clonazepam .25 mg/1 | TabletOral | TruPharma LLC | Sep 1, 2026 | 52817-305 |